0.7397
8.33%
+0.0569
Qilian International Holding Group ltd stock is currently priced at $0.7397, with a 24-hour trading volume of 5,805.
It has seen a +8.33% increased in the last 24 hours and a +3.17% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.6775 pivot point. If it approaches the $0.7249 resistance level, significant changes may occur.
Previous Close:
$0.6828
Open:
$0.6601
24h Volume:
5,805
Market Cap:
$26.44M
Revenue:
$46.47M
Net Income/Loss:
$-7.78M
P/E Ratio:
19.73
EPS:
0.0375
Net Cash Flow:
$-3.40M
1W Performance:
+1.86%
1M Performance:
+3.17%
6M Performance:
+70.01%
1Y Performance:
-23.91%
Qilian International Holding Group ltd Stock (QLI) Company Profile
Name
Qilian International Holding Group ltd
Sector
Phone
86 02 8647 75180
Address
Jiuquan Eco & Tech Dev Zn, Jiuquan
Qilian International Holding Group ltd Stock (QLI) Latest News
Qilian International Holding Group (NASDAQ:QLI) Stock Price Down 2.8% - Defense World
Defense World
Qilian International Reports Event to SEC - TipRanks.com - TipRanks
TipRanks
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
MSN
Qilian International Welcomes New Board Member - TipRanks.com - TipRanks
TipRanks
Financial Analysis: Qilian International Holding Group ltd (QLI)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
The Dwinnex
Qilian International Holding Group (NASDAQ:QLI) Trading Down 4.8% - Defense World
Defense World
Qilian International Holding Group ltd Stock (QLI) Financials Data
Qilian International Holding Group ltd (QLI) Revenue 2024
QLI reported a revenue (TTM) of $46.47 million for the quarter ending September 30, 2023.
Qilian International Holding Group ltd (QLI) Net Income 2024
QLI net income (TTM) was -$7.78 million for the quarter ending September 30, 2023.
Qilian International Holding Group ltd (QLI) Cash Flow 2024
QLI recorded a free cash flow (TTM) of -$3.40 million for the quarter ending September 30, 2023.
Qilian International Holding Group ltd (QLI) Earnings per Share 2024
QLI earnings per share (TTM) was -$0.22 for the quarter ending September 30, 2023.
About Qilian International Holding Group ltd
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
Cap:
|
Volume (24h):